Search
for
Sort by
Research 481–510 of 1000+
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- The PDGF/PDGFR pathway as a drug target
- Prostaglandin-Induced Hair Growth
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- A role of melatonin in neuroectodermal‐mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Congenital Adrenal Hyperplasia
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Hormonal Therapy for Acne
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Depression, anxiety and perceived stress in women with and without PCOS: a community-based study
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Current evaluation of amenorrhea
- Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Electrospun Nanofibers for Improved Angiogenesis: Promises for Tissue Engineering Applications
- How should postmenopausal androgen excess be evaluated?
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia